Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation
- PMID: 1423936
- DOI: 10.1161/01.res.71.6.1404
Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation
Abstract
The sarcomeric proteins and organization of cardiac myofibrils appeared intact in multiple unrelated patients with hypertrophic cardiomyopathy. In two subjects demonstrating the missense mutation at position 403 (Arg to Gln) in the beta-myosin heavy chain gene, total myosin and immunoreactive beta-myosin heavy chain levels were similar to those found in other patients with hypertrophic cardiomyopathy and various disease control subjects. No alteration in expression of the cardiac alpha-myosin heavy chain gene was observed. These results are consistent with the examined myosin heavy chain mutation, permitting proper accumulation and assembly of myosin while primarily impairing contractile function. The characteristic myocyte disarray would appear likely to be a secondary consequence of the mutations.
Similar articles
-
Molecular basis of hypertrophic and dilated cardiomyopathy.Tex Heart Inst J. 1994;21(1):6-15. Tex Heart Inst J. 1994. PMID: 8180512 Free PMC article. Review.
-
Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):11238-11243. doi: 10.1073/pnas.1802967115. Epub 2018 Oct 15. Proc Natl Acad Sci U S A. 2018. PMID: 30322937 Free PMC article.
-
Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.J Cell Biol. 1997 Apr 7;137(1):131-40. doi: 10.1083/jcb.137.1.131. J Cell Biol. 1997. PMID: 9105042 Free PMC article.
-
The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.Biochem J. 1995 Mar 1;306 ( Pt 2)(Pt 2):345-51. doi: 10.1042/bj3060345. Biochem J. 1995. PMID: 7887887 Free PMC article.
-
Mutations in cardiac myosin heavy chain genes cause familial hypertrophic cardiomyopathy.Mol Biol Med. 1991 Apr;8(2):159-66. Mol Biol Med. 1991. PMID: 1806760 Review.
Cited by
-
Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy.Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):589-93. doi: 10.1073/pnas.91.2.589. Proc Natl Acad Sci U S A. 1994. PMID: 8290568 Free PMC article.
-
R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.J Muscle Res Cell Motil. 2000;21(7):609-20. doi: 10.1023/a:1005678905119. J Muscle Res Cell Motil. 2000. PMID: 11227787
-
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.Biophys J. 1998 Dec;75(6):3023-30. doi: 10.1016/S0006-3495(98)77743-4. Biophys J. 1998. PMID: 9826622 Free PMC article.
-
A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.Heart. 1999 Nov;82(5):621-4. doi: 10.1136/hrt.82.5.621. Heart. 1999. PMID: 10525521 Free PMC article.
-
Molecular basis of hypertrophic and dilated cardiomyopathy.Tex Heart Inst J. 1994;21(1):6-15. Tex Heart Inst J. 1994. PMID: 8180512 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources